469 related articles for article (PubMed ID: 22677209)
1. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Maury E; Friedlander G; Cormier C
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):199-203. PubMed ID: 20398761
[TBL] [Abstract][Full Text] [Related]
3. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperparathyroidism.
Silva BC; Cusano NE; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.
Mikhail N
South Med J; 2011 Jan; 104(1):29-33. PubMed ID: 21079532
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
Walker MD; Saeed I; Lee JA; Zhang C; Hans D; Lang T; Silverberg SJ
Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism.
Inoue Y; Kaji H; Hisa I; Tobimatsu T; Naito J; Iu MF; Sugimoto T; Chihara K
Endocr J; 2008 Mar; 55(1):57-65. PubMed ID: 18187872
[TBL] [Abstract][Full Text] [Related]
11. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
[TBL] [Abstract][Full Text] [Related]
12. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
13. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
14. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
Souberbielle JC; Massart C; Brailly-Tabard S; Cormier C; Cavalier E; Delanaye P; Chanson P
Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency and primary hyperparathyroidism.
Nuti R; Merlotti D; Gennari L
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):45-9. PubMed ID: 21985980
[TBL] [Abstract][Full Text] [Related]
16. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
Majid H; Khan AH; Riaz M; Karimi H; Talati J
Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D treatment in primary hyperparathyroidism.
Rolighed L; Bollerslev J; Mosekilde L
Curr Drug Saf; 2011 Apr; 6(2):100-7. PubMed ID: 21524245
[TBL] [Abstract][Full Text] [Related]
18. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
19. [Increase of PTH in post-menopausal osteoporosis].
Cerdà D; Peris P; Monegal A; Albaladejo C; Martínez de Osaba MJ; Surís X; Guañabens N
Rev Clin Esp; 2011; 211(7):338-43. PubMed ID: 21596374
[TBL] [Abstract][Full Text] [Related]
20. Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study.
DiMarco A; Christakis I; Constantinides V; Regan L; Palazzo FF
World J Surg; 2018 Mar; 42(3):639-645. PubMed ID: 29349485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]